Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

NCT00872495 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-12-08

No results posted yet for this study

Summary

The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence

Conditions

Sponsors & Collaborators

  • Lahey Clinic

    lead OTHER

Principal Investigators

  • Kimberly Rieger-Christ, PhD · Lahey Clinic, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2028-10-31
Completion
2028-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00872495 on ClinicalTrials.gov